Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
Related Posts
Super-Star Sneaker Maker Golden Goose Postpones IPO
Italian fashion company Golden Goose, the maker of Super-Star sneakers worn by celebrities including Taylor Swift, has postponed its initial public offering, citing European market […]
Commerzbank Confirms Independent Strategy Ahead of Talks With UniCredit
The German lender said it planned to improve its profitability and boost shareholder returns as it grapples with a possible takeover attempt by Italy’s UniCredit.
X CEO Linda Yaccarino Contends With Pitfalls of Sharing Power With Elon Musk
Tensions over the division of labor with Musk have stymied some of Yaccarino’s initiatives.